The impact of insight on functioning in patients with schizophrenia or schizoaffective disorder receiving risperidone long-acting injectable

Journal of Nervous and Mental Disease

Volumn 195, Issue 12, 2007, Pages 976-982

  Gharabawi, Georges ^a,c   Bossie, Cynthia ^a,d   Turkoz, Ibrahim ^a   Kujawa, Mary ^a   Mahmoud, Ramy ^a   Simpson, George ^b  

^a JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

^d NONE   (United States)

Author keywords

Atypical antipsychotic; Function; Insight; Risperidone; Schizophrenia

Indexed keywords

LONG ACTING DRUG; RISPERIDONE;

ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; HUMAN; INTROSPECTION; MULTICENTER STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; STATISTICAL MODEL; TREATMENT DURATION; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; ANTIPSYCHOTIC AGENTS; AWARENESS; COGNITION DISORDERS; DELAYED-ACTION PREPARATIONS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RECURRENCE; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT;

EID: 37349093431     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31815c1982     Document Type: Article

References (36)

1. Addington J, Addington D (2000) Neurocognitive and social functioning in schizophrenia: A 2.5 year follow-up study. Schizophr Res. 44:47-56.
2. Amador XF, Flaum M, Andreasen NC, Strauss DH, Yale SA, Clark SC, Gorman JM (1994) Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 51:826-836.
3. Amador XF, Gorman JM (1998) Psychopathologic domains and insight in schizophrenia. Psychiatr Clin North Am. 21:27-42.
4. Amador XF, Strauss DH, Yale SA, Flaum MM, Endicott J, Gorman JM (1993) Assessment of insight in psychosis. Am J Psychiatry. 150:873-879.
5. Amador XF, Strauss DH, Yale SA, Gorman JM (1991) Awareness of illness in schizophrenia. Schizophr Bull. 17:113-132.
6. Dickerson F, Boronow JJ, Ringel N, Parente F (1999) Social functioning and neurocognitive deficits in outpatients with schizophrenia: A 2-year follow-up. Schizophr Res. 37:13-20.
7. Dickerson FB, Parente F, Ringel N (2000) The relationship among three measures of social functioning in outpatients with schizophrenia. J Clin Psychol. 56:1509-1519.
8. Doyle M, Flanagan S, Browne S, Clarke M, Lydon D, Larkin C, O'Callaghan E (1999) Subjective and external assessments of quality of life in schizophrenia: Relationship to insight. Acta Psychiatr Scand. 99:466-472.
9. Gagnon D, Nasrallah HA, Morosini PL (2006) The Personal and Social Performance scale: Measuring functional improvement in outpatients with stable schizophrenia. Presented at the American Psychiatric Association Annual Meeting, May 20-25, Toronto, Canada.
10. Gharabawi GM, Lasser RA, Bossie CA, Zhu Y, Amador X (2006) Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. Int Clin Psychopharmacol. 21:233-240.
11. Green MF, Kern RS, Braff DL, Mintz J (2000) Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the "right stuff"? Schizophr Bull. 26:119-136.
12. Guy W (1976) Clinical global impressions. ECDEU Assessment Manual for Psychopharmacology. Rockville (MD): U.S. Department of Health and Human Services.
13. Hofer A, Rettenbacher MA, Widschwendter CG, Kemmler G, Hummer M, Fleischhacker WW (2006) Correlates of subjective and functional outcomes in outpatient clinic attendees with schizophrenia and schizoaffective disorder. Eur Arch Psychiatry Clin Neurosci. 256:246-255.
14. Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13:261-276.
15. Keshavan MS, Rabinowitz J, DeSmedt G, Harvey PD, Schooler N (2004) Correlates of insight in first episode psychosis. Schizophr Res. 70(2-3): 187-194.
16. Koren D, Seidman LJ, Poyurovsky M, Goldsmith M, Viksman P, Zichel S, Klein E (2004) The neuropsychological basis of insight in first-episode schizophrenia: A pilot metacognitive study. Schizophr Res. 70(2-3):195-202.
17. Lehman AF (1999) Developing an outcomes-oriented approach for the treatment of schizophrenia. J Clin Psychiatry. 60(suppl 19):30-35; discussion 36-37.
18. Liddle PF (2000) Cognitive impairment in schizophrenia: Its impact on social functioning. Acta Psychiatr Scand Suppl. 400:11-16.
19. Locklear J, Lasser R, Rodriguez S, Turkoz I, Feifel D (2005) Maintenance therapy with long-acting risperidone: Functioning and quality of life in patients with schizophrenia or schizoaffective disorder. Presented at the International Congress on Schizophrenia Research, April 2-7, Savannah, GA.
20. Lysaker P, Bell M (1994) Insight and cognitive impairment in schizophrenia. Performance on repeated administrations of the Wisconsin Card Sorting Test. J Nerv Ment Dis. 182:656-660.
21. Lysaker PH, Bryson GJ, Bell MD (2002) Insight and work performance in schizophrenia. J Nerv Ment Dis. 190:142-146.
22. Lysaker PH, Bryson GJ, Lancaster RS, Evans JD, Bell MD (2003) Insight in schizophrenia: Associations with executive function and coping style. Schizophr Res. 59:41-47.
23. Marder SR, Davis JM, Chouinard G (1997) The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J Clin Psychiatry. 58:538-546.
24. Milev P, Ho BC, Arndt S, Andreasen NC (2005) Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: A longitudinal first-episode study with 7-year follow-up. Am J Psychiatry. 162:495-506.
25. Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: A meta-analysis. Schizophr Res. 61:75-88.
26. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R (2000) Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand. 101:323-329.
27. Nakano H, Terao T, Iwata N, Hasako R, Nakamura J (2004) Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res. 127(1-2):65-72.
28. Saeedi H, Addington J, Addington D (2007) The association of insight with psychotic symptoms, depression and cognition in early psychosis: A 3-year follow-up. Schizophr Res. 89(1-3):123-128.
29. Schwartz RC (1998) Insight and illness in chronic schizophrenia. Compr Psychiatry. 39:249-254.
30. Schwartz RC, Cohen BN, Grubaugh A (1997) Does insight affect long-term impatient treatment outcome in chronic schizophrenia? Compr Psychiatry. 38:283-288.
31. Simpson GM, Mahmoud RA, Lasser RA, Kujawa M, Bossie CA, Turkoz I, Rodriguez S, Gharabawi GM (2006) A 1-year double-blind study of 2 doses of long-acting risperidone in stable patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 67:1194-1203.
32. Smith TE, Hull JW, Huppert JD, Silverstein SM (2002) Recovery from psychosis in schizophrenia and schizoaffective disorder: Symptoms and neurocognitive rate-limiters for the development of social behavior skills. Schizophr Res. 55:229-237.
33. Strauss JS, Carpenter WT Jr (1977) Prediction of outcome in schizophrenia. III. Five-year outcome and its predictors. Arch Gen Psychiatry. 34:159-163.
34. Valenstein M, Copeland LA, Blow FC, McCarthy JF, Zeber JE, Gillon L Fitzpatrick R, Jenkinson C (2002) Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care. 40:630-639.
35. Weiden PJ, Kozma C, Grogg A, Locklear J (2004) Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv. 55:886-891.
36. Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, Bingham CR, Stavenger T (2000) Self-report quality of life measure for people with schizophrenia: The SQLS. Br J Psychiatry. 177:42-46.